Product Introduction
Tri Betrol Forte 0.3/1/500 mg Tablet SR is used to effectively manage blood sugar levels in patients with type 2 diabetes. It combines:
-
Voglibose (0.3 mg) – an alpha-glucosidase inhibitor that slows carbohydrate absorption.
-
Glimepiride (1 mg) – a sulfonylurea that stimulates insulin secretion from the pancreas.
-
Metformin SR (500 mg) – a biguanide that reduces liver glucose production and increases insulin sensitivity.
This sustained-release formulation helps in better glycemic control throughout the day.
Uses
-
Management of Type 2 Diabetes Mellitus
-
Especially effective in patients with postprandial hyperglycemia
Benefits
-
Controls fasting and post-meal blood glucose
-
Reduces risk of diabetes-related complications
-
Works through complementary mechanisms
-
Once-daily dosing for convenience
Composition
Each sustained-release tablet contains:
-
Voglibose 0.3 mg
-
Glimepiride 1 mg
-
Metformin Hydrochloride (SR) 500 mg
Side Effects
Common:
-
Flatulence
-
Nausea
-
Diarrhea
-
Hypoglycemia
-
Abdominal bloating
Report to your doctor if severe or persistent side effects occur.
Safety Advice
-
Take with food to avoid gastrointestinal issues and hypoglycemia
-
Avoid alcohol while on this medication
-
Not suitable for patients with kidney or liver dysfunction without medical supervision
-
Regular blood sugar monitoring is necessary
-
Inform your doctor if pregnant or breastfeeding
